Akdeniz University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Konyaalti Turkey (1982)

Organization Overview

First Clinical Trial
2007
NCT01423500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Akdeniz Univercity | Akdeniz Üniversitesi | Akdeniz Universitesi, Akdeniz University Faculty of Nursing | Akdeniz Üniversitesi Antalya Sağlık Yüksekokulu | Akdeniz University | Akdeniz University, Department of Child Health and Disease Nursing | Akdeniz University Faculty of Nursing | Akdeniz University Health Sciences Institute | Akdeniz University Hospital | Akdeniz University Medical Faculty | Akdeniz University Nursing Faculty | AKDENIZ UNIVERSITY PHYSICAL THERAPY | Akdeniz Universty | Ayşegül İşler Dalgıç | Dep. of Paediatric Haematology-Oncology and HSCT, Akdeniz University School of Medicine | doğu akdeniz üniversitesi | Gokce Yagmur Gunes Gencer | i.keser@akdeniz.edu.tr | Serife Bilge Duran | Şeyma Demiralay

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 4)

Ankle Injuries (Phase 4)

Back Pain (Phase 4)

Colic (Phase 4)

Dysmenorrhea (Phase 4)

Dyspepsia (Phase 4)

Emergencies (Phase 4)

Infertility (Phase 4)

Infertility, Female (Phase 4)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 3)

Low Back Pain (Phase 4)

Migraine Disorders (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Psoriasis (Phase 3)

Renal Colic (Phase 4)

Sciatica (Phase 4)

Sprains and Strains (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 20